Company news
Beyond Air, Inc. news in 2022
Beyond Air, Inc.'s news releases, calls and decks from 2022, newest first.
Beyond Cancer® Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide (UNO) Induced a Systemic Response that Prevents Metastases
December 12, 2022
Beyond Cancer™ Presents Promising New In Vivo Data Showing Ultra-High Concentration Nitric Oxide Therapy (UNO) in Combination with Anti-PD-1 During the Society for Immunotherapy of Cancer (SITC) 2022 Annual Meeting
November 9, 2022
Beyond Air® Reports Financial Results for the Second Quarter of Fiscal Year 2023
November 7, 2022
Beyond Air® Announces Positive Data for Inhaled Nitric Oxide (NO) to Treat COVID-19 with LungFit® PRO in a Poster Presentation at IDWeek 2022
October 23, 2022
Beyond Air® Schedules Second Fiscal Quarter 2023 Financial Results Conference Call and Webcast
October 19, 2022
Beyond Air® Announces Positive Data from At-Home Pilot Study in Patients with Refractory NTM Lung Infection Treated with (NO) using the LungFit® GO at the CHEST Annual Meeting 2022
October 16, 2022
Beyond Cancer™ to Present Pre-Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2022 SITC Annual Meeting
October 4, 2022
Beyond Air® Announces that Annals of the American Thoracic Society Published a Review of the Third Pilot Study of High Dose Nitric Oxide for Bronchiolitis
October 2, 2022
Beyond Air® Affiliate Beyond Cancer™ Doses Initial Patient in First-in-Human Phase 1 Study of Ultra-High Concentration Nitric Oxide Therapy at Tel Aviv Sourasky Medical Center (Ichilov)
August 22, 2022
Beyond Air® Reports Financial Results for the First Quarter of Fiscal Year 2023
August 10, 2022
Beyond Air® Schedules First Fiscal Quarter 2023 Financial Results Conference Call and Webcast
July 26, 2022
Beyond Air’s LungFit® PH Receives FDA Approval to Treat Term and Near-Term Neonates with Hypoxic Respiratory Failure
June 27, 2022
Beyond Air® Reports Financial Results for Fourth Fiscal Quarter and Year-End 2022
June 27, 2022
Beyond Air® Announces Fiscal Year End 2022 Financial Results Conference Call and Webcast Moved to Tuesday, June 28th
June 13, 2022
Beyond Cancer™ Announces the Appointment of Jedidiah Monson, M.D. to Chief Medical Officer
May 31, 2022
Beyond Air® Presents Positive Study Update from the At-Home LungFit® GO Pilot Study for Nontuberculous Mycobacterial Lung Disease at the American Thoracic Society International Conference 2022
May 16, 2022
Beyond Air® Schedules Fiscal Year 2022 Financial Results Conference Call and Webcast
May 15, 2022
Beyond Air® Reports Positive Long-Term Safety Data for High Concentration Inhaled Nitric Oxide in Bronchiolitis at the Pediatric Academic Societies Meeting 2022
April 24, 2022
Beyond Cancer™ Announces New Preclinical Data Presented at American Association for Cancer Research (AACR) Showing Ultra-High Concentration Nitric Oxide Therapy Anti-Tumor Effect
April 10, 2022
Beyond Air® Reports Financial Results for the Third Quarter of Fiscal Year 2022
February 9, 2022
Beyond Air® Announces Participation at Upcoming Investor Conferences in March 2022
February 7, 2022
Beyond Air® Announces Two Appointments to Beyond Cancer™ Board of Directors
February 2, 2022
Beyond Air® Schedules Third Fiscal Quarter 2022 Financial Results Conference Call and Webcast
January 26, 2022
Calls in 2022
Decks in 2022
- Pediatric Academic Societies (PAS) Meeting 2022
Conference · 15 slides · 2022